Anti-Angiogenesis Strategies

ANGEOO is exploring innovative anti-angiogenic strategies to identify potential therapies for diseases driven by pathological blood vessel formation.

Our approach leverages a novel angiogenesis model to screen and evaluate potential anti-angiogenic agents. Beyond the well-established VEGF signaling pathway, ANGEOO is exploring a broader range of molecular targets and biological mechanisms involved in the initiation, regulation, and progression of angiogenesis.

By expanding the therapeutic focus beyond canonical VEGF pathways, ANGEOO aims to identify differentiated anti-angiogenic strategies with the potential to address the limitations of current treatments.